Human Genome Sciences Cash Flow Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Net Operating Cash Flow | (260.3) | (174.7) | (146.8) |
| Net Investing Cash Flow | 239.1 | 113.2 | (21.5) |
| Net Financing Cash Flow | 1.5 | (0.6) | 253.0 |
| Net Change in Cash | (19.6) | (62.1) | 84.7 |
| Depreciation & Amortization | 21.4 | 22.1 | 20.1 |
| Capital Expenditures | (9.7) | (16.2) | (9.7) |
| Cash Dividends Paid | -- | -- | -- |
© 2009 Morningstar, Inc. Financial Data provided by
